Levetiracetam Solution
Product Images NDC 31722-574

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 31722-574). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure.jpg (Figure)

A bar chart comparing the percentage of patients across three groups: Placebo (7.4%), Levetiracetam 1000 mg/day (37.1%), and Levetiracetam 3000 mg/day (39.6%). The y-axis represents the percentage of patients, and the sample sizes are indicated below each bar.*

FDA Label Image

Figure1.jpg (Figure1)

Bar chart depicting the percentage of patients across three treatment groups: Placebo (6.3%), Levetiracetam 1000 mg/day (20.8%), and Levetiracetam 2000 mg/day (35.2%). The vertical axis represents the percentage of patients, and the horizontal axis lists the groups with their respective sample sizes.*

FDA Label Image

Figure2.jpg (Figure2)

A bar graph comparing the percentage of patients between two groups: Placebo (N=104) with 14.4% and Levetiracetam 3000 mg/day (N=180) with 39.4%. The y-axis represents the percentage of patients, ranging from 0% to 45%.*

FDA Label Image

Figure3.jpg (Figure3)

A bar graph comparing the percentage of patients between placebo and Levetracetam oral solution 100 mg/mL groups. The graph shows 19.6% for placebo (N=97) and 44.6% for Levetracetam (N=101), indicating a higher percentage in the Levetracetam group.*

FDA Label Image

Figure4.jpg (Figure4)

A bar chart comparing the percentage of a certain outcome between two groups: Placebo (N=84) and Levetiracetam (N=79). The Levetiracetam group shows a higher percentage (72.2%) compared to the Placebo group (45.2%).*

FDA Label Image

Figure5

A bar graph showing two vertical bars comparing percentages of patients. The first bar indicates 19.6% and the second bar indicates 43.1%, with an asterisk above the second bar suggesting statistical significance or emphasis. The y-axis is labeled as the percentage of patients, ranging from 0% to 45%.*

FDA Label Image

Levetiracetamoscontlabel1

Levetiracetam Oral Solution USP 100 mg/mL bottle label from Camber Pharmaceuticals, Inc. The label displays the product name, strength, dosage form, quantity of 16 fl oz (473 mL), NDC 31722-574-47, and pharmacist dispensing instructions. It includes storage instructions, a barcode, and manufacturer details referencing Annora Pharma Pvt. Ltd. in Telangana, India.*

FDA Label Image

Levetiracetamoscontlabel2

Levetiracetam oral solution USP 100 mg/mL in a 16 fl oz (473 mL) bottle, labeled by Camber Pharmaceuticals, Inc. The label includes dosing and storage instructions, a pharmacist advisory to dispense the Medication Guide to each patient, and contact information. The bottle is marked Rx only and states it is manufactured for Camber Pharmaceuticals in Piscataway, NJ. Additional manufacturer information for Hetero Labs Limited in Hyderabad, India, is also present.*

FDA Label Image

Logo

FDA Label Image

Structure.jpg (Structure)

Chemical structure of the active ingredient levetiracetam shown with molecular groups including a pyrrolidine ring and amide functional group. The diagram illustrates key atoms and bonds in the levetiracetam molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.